2025 Annual Meeting | C38 - Case Studies: Challenges in Stroke Treatment and Prevention

��ɫ��

2025 Annual Meeting | C38 - Case Studies: Challenges in Stroke Treatment and Prevention

Date Saturday 04/05/25

Time 05:00 PM - 07:00 PM PDT Add To Calendar

Location San Diego Convention Center | 30C-E

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Larry B. Goldstein, MD, FAHA, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Using case examples, presenters will engage participants in a discussion and review of contrioversial topics in stroke prevention and acute treatment.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Quality Improvement

Program Level Intermediate

Program Tracks Brain Health

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Audience Participation

Program Materials Program Evaluations

Event Timeline
05:00 PM - 05:05 PM PDT	Speaker	Introduction Larry B. Goldstein, MD, FAHA, FAAN
05:05 PM - 05:40 PM PDT	Speaker	Case Discussions Larry B. Goldstein, MD, FAHA, FAAN
05:40 PM - 06:15 PM PDT	Speaker	Case Discussions Kara J. Swafford, MD
06:15 PM - 06:50 PM PDT	Speaker	Case Discussions Lawrence R. Wechsler, MD, FAAN
06:50 PM - 07:00 PM PDT	Q&A	Questions and Answers Larry B. Goldstein, MD, FAHA, FAAN, Kara J. Swafford, MD, Lawrence R. Wechsler, MD, FAAN

Faculty Disclosures
Larry B. Goldstein, MD, FAHA, FAAN	The institution of Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. Dr. Goldstein has received intellectual property interests from a discovery or technology relating to health care. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Kara J. Swafford, MD	Dr. Swafford has nothing to disclose.
Lawrence R. Wechsler, MD, FAAN	Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Wechsler has stock in Forest Devices.

��ɫ����

��ɫ����

��ɫ��

��ɫ��